Bioatla, INC. (BCAB) — DEF 14A Filings
All DEF 14A filings from Bioatla, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
BioAtla Seeks Shareholder Nod for Equity Raise, Reverse Split to Avoid Delisting
— Dec 5, 2025 Risk: high
BioAtla, Inc. (BCAB) is holding a Special Meeting on December 30, 2025, to address critical financial and listing compliance issues. The company seeks stockhold -
BioAtla Executive Compensation Details Revealed
— Apr 24, 2025 Risk: medium
BioAtla, Inc. filed a DEF 14A on April 24, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX